Astria Therapeutics, Inc. Common Stock
ATXS
ATXS: Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
moreShow ATXS Financials
Recent trades of ATXS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ATXS's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ATXS's company Twitter account
Number of mentions of ATXS in WallStreetBets Daily Discussion
Recent insights relating to ATXS
Recent picks made for ATXS stock on CNBC
ETFs with the largest estimated holdings in ATXS
Flights by private jets registered to ATXS